Health
Diagnostic, therapeutic advance for rare neurodegenerative disorder – Medical Xpress
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type…
Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3)a disease that has no cure. They also have clarified the role of a gene target associated with the disease.
The inherited disease is linked to a mutation in the ATXN3 gene. This mutation, which affects the central nervous system, appears between the ages of 40 and 70, and is characterized by an unsteady gait, loss of muscle control,…
-
Noosa News10 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News22 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News23 hours agoFarmgate Backpackers leads with integrity amid industry challenges
-
General17 hours agoWall St futures bounce, Asia still shaky